Combination Therapy of Pyrotinib and Metronomic Vinorelbine in HER2+ Advanced Breast Cancer after Trastuzumab Failure (PROVE): A Prospective Phase 2 Study.
Saved in:
| Title: | Combination Therapy of Pyrotinib and Metronomic Vinorelbine in HER2+ Advanced Breast Cancer after Trastuzumab Failure (PROVE): A Prospective Phase 2 Study. |
|---|---|
| Authors: | Hao, Chunfang1,2,3 (AUTHOR) haochunfang@tjmuch.com, Wang, Xu1,2 (AUTHOR), Shi, Yehui1,2 (AUTHOR), Tong, Zhongsheng1,2 (AUTHOR), Li, Shufen1,2 (AUTHOR), Liu, Xiaodong1,2 (AUTHOR), Zhang, Lan1,2 (AUTHOR), Zhang, Jie3 (AUTHOR), Meng, Wenjing1,2 (AUTHOR), Zhang, Li1,2 (AUTHOR) |
| Source: | Cancer Research & Treatment. Apr2025, Vol. 57 Issue 2, p434-442. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 15982998 |
|---|---|
| DOI: | 10.4143/crt.2024.340 |
